NextMRI Prototype Evaluation in Suspected MS: MRI Comparisons
A study is planned to scan 50 patients aged 18 to 65 with suspected multiple sclerosis using both a standard 3T MRI and the NextMRI prototype. The aim is to evaluate the performance of the NextMRI device over a follow-up period of one year.
- Tags
- #MSResearch
- Most relevant to
- —
- Source
- Read original source
Why it matters
This study could assess whether the NextMRI prototype offers advantages over traditional imaging methods, potentially influencing future diagnostic practices in multiple sclerosis.
What this does not prove
No results have been posted yet, and this trial does not establish the NextMRI's efficacy or effectiveness in diagnosing MS as it is merely a planned study.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Interventional
- Participants / samples
- 75 · actual
- Randomised
- Not reported
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- Not reported
- Evidence reviewed
- Trial registry record
- Regulatory approval
- No
- Research areas
- Not classified
Original sources
Supporting passages (10)
study design"studyType": "INTERVENTIONAL"
sample size"count": 75
sample size basis"type": "ACTUAL"
regulatory approval"isFdaRegulatedDrug": false, "isFdaRegulatedDevice": false
intervention"Device: MRI"
comparator"description": "Standard 3T MRI Scan"
primary endpoint"measure": "Radiological reports to Evaluate NextMRI prototype performance"
follow up"timeFrame": "1 year"
findings"description": "A total of 50 patients aged between 18 and 65 years with suspected multiple sclerosis will be scanned using both the 3T MRI and the NextMRI prototype.",
limitationsTrial registry record. Publication date: unknown. No results are posted. Planned enrolment and endpoints are not findings.
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.